NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

50 hedge funds and large institutions have $12.8M invested in NeuBase Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-2
Holders Change %
-3.85%
% of All Funds
1.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
9
Reduced
9
Closed
10
Calls
$307K
Puts
$1.24M
Net Calls
-$934K
Net Calls Change
-$2.63M
Name Holding Trade Value Shares
Change
Shares
Change %
BBA
51
Baker Bros. Advisors
New York
-$2.27M -926 Closed
PP
52
PDT Partners
New York
-$270K -110 Closed
Balyasny Asset Management
53
Balyasny Asset Management
Illinois
-$172K -70 Closed
OAM
54
Oxford Asset Management
United Kingdom
-$161K -66 Closed
JPMPWA
55
J.P. Morgan Private Wealth Advisors
California
-$160K -65 Closed
EWM
56
Edge Wealth Management
New York
-$148K -60 Closed
BHA
57
Beech Hill Advisors
New York
-$104K -42 Closed
Simplex Trading
58
Simplex Trading
Illinois
-$34K -14 Closed
WA
59
WFG Advisors
Texas
-$6K -3 Closed
IA
60
IFP Advisors
Florida
-$5K -2 Closed
Citigroup
61
Citigroup
New York
-$1K